Chronic-pain shelves grow as baby boomers age
NEW YORK —It isn’t just the weekend-warriors with aches and pains from the company’s softball game that make up the lion’s share of customers buying external analgesics today.
That acute-pain need marked a key demographic in the past decade, thanks in large part to an active-later-in-life baby-boomer generation, but those baby boomers are fast becoming card-carrying seniors in search of chronic-pain solutions. And with that older demographic comes more than sore muscles after an active weekend; there’s an increased incidence of arthritis, osteoporosis, diabetes-related neuropathy or any number of age-related chronic pain issues.
“This baby-boomer generation presents tremendous growth in a traditional segment,” said Scott Matolka, Performance Health director of marketing, especially as growing older means more aches and pains. “[Baby boomers] are incredibly independent [and] remaining independent,” he said, pursuing a more active lifestyle than perhaps their parents experienced.
Merchandising specifically against chronic pain may be an ideal incremental opportunity, said Gregg Harwood, president of Thermionics. “Each day, the [sufferer] wakes up and has to do something in order to ease the pain,” he said. And soothing that pain is more than likely a moving target, literally. “There’s always something. Each person really has to design their own regimen that deals with that pain because it’s unique to them,” he added. That may explain why that sufferer is regularly in the pain-relief aisles, and for that reason chronic pain sufferers represent larger marketbasket opportunities specifically relative to the condition that drove them in search of that pain relief. According to recent Thermionics research, 8-out-of-10 consumers treating chronic pain purchase multiple solutions across internal analgesics, external rubs, heat/ice therapy and body support devices.
Top 10 fastest growing external analgesic brands
|1||Store brand||Muscle/body support||$79.9||3.5%|
|2||Icy Hot||External rubs||66.7||9.8|
|5||Store brand||Heat/ice packs||44.4||36.8|
|6||Store brand||External rubs||30.5||5.4|
|7||Mueller Sport Care||Muscle/body support||15.9||41.1|
|8||Tiger Balm||External rubs||10.5||10.6|
Currently, sales of external analgesics—including heat/ice packs, external analgesic rubs and muscle/body support devices—are relatively flat with sales up slightly at 0.4% to $728 million across food, drug and mass (minus Walmart), courtesy Information Resources Inc. for the 52 weeks ended Jan. 24. But within each of those subcategories there are some fast-growing brands. Within analgesic rubs, market leader Icy Hot—which soon may be marketed as a Sanofi-Aventis consumer product—has engineered 9.8% growth to reach $66.7 million in sales. There’s also Haw Par Healthcare’s venerable brand Tiger Balm, ($10.5 million, up 10.6%), Performance Health’s Perform ($6.9 million, up 44%) and Origin Biomed’s homeopathic pain reliever Neuragen PN ($5.4 million, up 50.1%).
External analgesics category sales
Within heat/ice packs there is a resurgent Thermacare brand, now being supported by Pfizer Consumer Healthcare, with 3% growth generating $48.3 million in sales. And Thermionics’ Thermipaq ($5.6 million, up 55.5%) satisfies the value-oriented consumer with its thermal ceramic technology that allows for the same reusable pack to be frozen for cold relief and microwaved for heat relief. Within muscle/body support, Mueller Sport Care is experiencing growth of 41.1%, reaching sales of $15.9 million.
While more consumers are driving to their local pharmacies in search of a pain product, or some combination of products, to help manage a chronic pain need as opposed to treating an acute pain, age isn’t the only driving force behind external analgesics these days. The recession economy is tempering a new value-conscious consumer, and she’s turning more often to self-care options in lieu of visiting a doctor about her aches and pains.
There’s also an increased awareness around, and appreciation for, possible drug-drug interactions and adverse side effects associated with the use of internal analgesics or other systemic medicines. In fact, OTC analgesics are not recommended for use as a chronic pain solution without a doctor’s recommendation, but an analgesic balm or such nondrug therapies as heat or cold represent an alternative to those internal pain-relieving solutions.
Survey finds shoppers with a plan spend most money
CHICAGO Coupon clippers and shoppers that plan their excursions to the supermarket are more likely to spend more money, according to a Henkel survey.
Henkel, a manufacturer of such brands as Dial soap, said that those who go to supermarkets with the intent to shop and save yield more profit than carefree shoppers. On average, coupon clippers spent more than $7,100 last year. What’s more, Henkel added, these shoppers accounted for 31% of spending on packaged goods in 2009, even though they only make up 26% of U.S. households.
Another interesting fact, the CPG maker noted, is that shoppers with a plan also are less likely to shop at new stores.
The survey was baed on tracking of about 40,000 households performed by ACNielsen and Information Resources Inc.
Bayer aspirin quick release crystals
CVS had this citrus-flavored Bayer aspirin quick release crystals clip-stripped within adult dentures. And while this product isn’t the 81 mg of aspirin recommended for daily consumption to prevent a second heart attack (it contains 850 mg in each powder pouch), there is still a very strong need for this kind of easily stored/quickly administered aspirin product for seniors.
Sufferers of any heart attack are recommended to chew and swallow aspirin just after they’ve dialed 911 and called for help. As the first aid for heart attacks, aspirin makes platelets less sticky and can minimize blood clot formation and prevent further blockage of the artery.